Raquel Gonzalez Rivera

FDA investigator

Appears on 7 documents from 2013 to 2023, mostly at sites in Puerto Rico. Most often cites laboratory records (21 CFR 211.194(a)).

7
Documents on file
4.6
Observations per 483
2013
First seen
2023
Most recent

What they cite most

From 32 observations

Activity by year

2013: 2, 2018: 1, 2021: 1, 2023: 3

Where

Puerto Rico 5 · India 2

Is Raquel Gonzalez Rivera coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Hetero Labs LimitedJul 21, 2023 · Hyderabad, India
483 LUPIN LIMITEDJul 11, 2023 · Nagpur, India
483 Janssen Ortho LLCMar 28, 2023 · Gurabo, Puerto Rico
483 Galephar Pharmaceutical Research IncJun 9, 2021 · Juncos, Puerto Rico
483 Janssen Ortho LLCAug 28, 2018 · Gurabo, Puerto Rico
483 Viatris Pharmaceuticals LLCAug 20, 2013 · Barceloneta, Puerto Rico
483 Lilly del Caribe, Inc.Jul 22, 2013 · Carolina, Puerto Rico

About this profile

What does Raquel Gonzalez Rivera inspect?

Raquel Gonzalez Rivera appears on 7 documents on file covering 6 sites, mostly in Puerto Rico.

What do they cite most often?

21 CFR 211.194(a) (laboratory records), followed by 21 CFR 211.192 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Raquel Gonzalez Rivera is dated Jul 21, 2023.